#1 Clinical Trials Search in Europe

MORPHINE

Morphine is one of the most widely used opioid medications for pain management in medical settings. It plays a critical role in controlling moderate to severe pain associated with various conditions and surgical procedures. This article examines how morphine is being investigated in clinical trials across different medical contexts, from post-surgical pain management to specialized applications in cancer care. By understanding the current research on morphine, patients and healthcare providers can make more informed decisions about pain management strategies while being aware of both benefits and potential concerns.

Table of Contents

Introduction to Morphine

Morphine is a potent opioid medication primarily used for the treatment of moderate to severe pain. It belongs to a class of drugs known as opioid analgesics, which work by binding to opioid receptors in the brain and spinal cord to reduce the sensation of pain. Morphine is considered one of the standard treatments for severe pain management in both acute and chronic settings [1].

Morphine is also known by several brand names, including MST Continus, KADIAN, MorphaBond ER, and Duramorph. The medication is available in various formulations, including immediate-release (IR) and extended-release (ER) forms, allowing for different durations of pain relief [2].

Medical Uses of Morphine

Morphine is primarily used to treat various types of pain, including:

  • Post-surgical pain: Morphine is commonly used for pain management after surgeries such as cesarean sections, laparoscopic procedures, and thoracotomies [3].
  • Cancer-related pain: It is effective for controlling pain in patients with cancer [4].
  • Acute pain: Conditions such as renal colic, abdominal pain, and musculoskeletal pain may be treated with morphine when other pain medications are insufficient [5].
  • Chronic non-cancer pain: In some cases, morphine may be prescribed for long-term management of severe chronic pain, such as that from osteoarthritis [6].

Methods of Administration

Morphine can be administered through various routes, each with different onset times and durations of action:

  • Intravenous (IV): Direct injection into a vein provides the fastest onset of action (within minutes) and is commonly used in hospital settings for acute pain management [7].
  • Oral: Available as tablets, capsules, or liquid, oral morphine has a slower onset but is convenient for outpatient use. Extended-release formulations (like MorphaBond ER or KADIAN) can provide pain relief for up to 24 hours [8].
  • Intrathecal/Epidural: Injection into the spinal fluid (intrathecal) or space around the spinal cord (epidural) provides targeted pain relief with lower doses. This method is often used for post-surgical pain management and during childbirth [9].
  • Patient-Controlled Analgesia (PCA): A system that allows patients to self-administer small doses of morphine when needed, within predetermined safety limits [10].

Effectiveness for Pain Management

Morphine is highly effective for managing moderate to severe pain. Clinical studies have consistently shown its efficacy in various pain conditions:

  • Post-surgical pain: Studies have demonstrated that morphine significantly reduces pain scores following surgical procedures. For example, in laparoscopic sigmoidectomy, morphine PCA (Patient-Controlled Analgesia) effectively controlled postoperative pain as measured by EVA (postoperative pain) scales [3].
  • Acute pain in emergency settings: In emergency departments, morphine is effective for controlling severe acute pain from conditions such as renal colic, abdominal pain, and back pain [7].
  • Chronic pain: Extended-release morphine formulations have shown effectiveness for long-term pain management, with studies reporting improved pain scores over 12-week periods in patients with conditions like osteoarthritis [6].

Pain relief typically begins within 15-60 minutes of oral administration and within minutes when given intravenously. The duration of effect varies depending on the formulation, ranging from 4-6 hours for immediate-release forms to 12-24 hours for extended-release versions [8].

Comparisons with Other Pain Medications

Morphine has been compared to various other pain medications in clinical trials:

  • Morphine vs. Ketamine: A randomized controlled trial comparing low-dose ketamine to morphine for acute pain control in the emergency department found both medications effective, but with different side effect profiles. Ketamine may cause more agitation, while morphine is more likely to cause respiratory depression [5].
  • Morphine vs. Methadone: In a study of patients undergoing laparoscopic cholecystectomy, methadone showed comparable analgesic effects to morphine but with a longer duration of action. Both medications improved quality of recovery scores, but methadone required less frequent dosing [11].
  • Morphine vs. Remifentanil combination: The combination of remifentanil and morphine for post-thoracotomy pain showed improved pain control compared to morphine alone, suggesting potential benefits of combining different opioids in certain settings [12].
  • Morphine vs. Regional anesthesia: Studies comparing morphine to techniques like caudal bupivacaine or pericapsular nerve group (PENG) blocks show that regional anesthesia may provide comparable or better pain relief with fewer systemic side effects in specific surgical scenarios [13].

Side Effects and Safety Concerns

Morphine can cause various side effects, ranging from common and mild to rare but serious:

Common side effects include:

  • Nausea and vomiting: These are among the most common side effects, affecting many patients who receive morphine [11].
  • Constipation: Opioids slow intestinal motility, leading to constipation in most patients using morphine regularly [14].
  • Drowsiness and sedation: Morphine can cause sleepiness, especially when treatment is first started or dosage is increased [15].
  • Itching: Particularly common with intrathecal (spinal) administration [16].

More serious side effects include:

  • Respiratory depression: Slowed or shallow breathing is the most dangerous side effect and requires immediate medical attention [17].
  • Hypotension: Morphine can cause blood pressure to drop, especially when changing positions [10].
  • Urinary retention: Difficulty urinating may occur, particularly in older male patients [18].

Long-term concerns:

  • Tolerance: Over time, higher doses may be needed to achieve the same pain relief [12].
  • Physical dependence: The body becomes accustomed to the medication, leading to withdrawal symptoms if suddenly stopped [19].
  • Risk of addiction: There is potential for psychological dependence and addiction, though this risk is often overstated in patients using morphine appropriately for pain [2].

Special Populations

Pediatric patients: Morphine can be used in children, but dosing must be carefully adjusted based on weight and age. Specialized pain assessment tools like the CRIES (Crying, Requires oxygen, Increased vital signs, Expression, Sleeplessness) for neonates and FLACC (Face, Legs, Activity, Cry, Consolability) for older infants are used to evaluate pain and morphine effectiveness [13].

Elderly patients: Older adults may be more sensitive to the effects of morphine and typically require lower doses. They are also at increased risk for side effects like confusion, constipation, and respiratory depression [19].

Pregnant and breastfeeding women: Morphine crosses the placenta and can be used in pregnancy when the benefits outweigh the risks. It’s commonly used for pain management during labor and after cesarean sections. Low doses in breastfeeding mothers are generally considered acceptable, but infants should be monitored for sedation [20].

Patients with obstructive sleep apnea: Caution is needed as morphine can worsen sleep-disordered breathing. Research has examined the effects of intravenous morphine on patients with moderate obstructive sleep apnea, showing the importance of careful monitoring in this population [17].

How Morphine Works in the Body

Understanding how morphine is processed in the body can help patients better comprehend its effects and limitations:

  • Absorption: When taken orally, morphine undergoes significant first-pass metabolism in the liver, resulting in lower bioavailability (about 30-40%) compared to intravenous administration. Food can affect the absorption of some morphine formulations [21].
  • Distribution: Once in the bloodstream, morphine is distributed throughout the body, including to the brain where it exerts its pain-relieving effects. It crosses the blood-brain barrier, though not as efficiently as some other opioids [22].
  • Metabolism: Morphine is primarily metabolized in the liver through a process called glucuronidation, primarily by the enzyme UGT2B7. It forms two main metabolites: morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G). Interestingly, M6G is actually more potent as a pain reliever than morphine itself [23].
  • Elimination: Morphine and its metabolites are primarily eliminated through the kidneys. The half-life of morphine is approximately 2-4 hours, meaning it takes this long for half of the drug to be eliminated from the body [24].

Individual genetic differences can affect how morphine is metabolized. Research has shown that variations in genes like CYP2D6 and UGT2B7 can influence how effectively morphine works and how likely someone is to experience side effects [25].

Understanding these factors helps explain why morphine may work differently in different people and why dosages often need to be individualized for optimal pain control with minimal side effects.

Application Administration Methods Key Clinical Findings Considerations/Side Effects
Post-surgical Pain – Intravenous (IV)
– Patient-controlled analgesia (PCA)
– Neuraxial (spinal/epidural)
– Oral immediate/extended release 		– Effective for moderate to severe pain
– Often combined with non-opioid medications
– Different dosing based on surgery type 		– Respiratory depression
– Nausea/vomiting
– Itching/pruritus
– Sedation
Acute Pain in Emergency Settings – IV bolus administration
– Compared to ketamine in some trials 		– Fast onset of action
– Effective for severe acute pain
– Alternative options may have advantages 		– Risk of hypotension
– Monitoring required
– Drug interactions
– Potential for misuse
Specialized Applications – Caudal blocks in pediatrics
– With regional nerve blocks
– Various extended-release formulations 		– Effective for localized pain control
– Can reduce total opioid consumption
– Age-specific considerations important 		– Special dosing for vulnerable populations
– Careful monitoring in children
– Caution in sleep apnea patients
Comparative Studies – Versus other opioids (fentanyl, remifentanil)
– Versus non-opioid alternatives
– As part of multimodal strategies 		– Remains a standard of care
– Different risk/benefit profiles based on route
– Combination therapy often superior 		– Different opioids have unique profiles
– Individual patient factors affect response
– Growing interest in opioid-sparing approaches
Novel Formulations – Abuse-deterrent formulations
– Extended-release capsules
– Combination with naltrexone 		– May reduce misuse potential
– Can provide longer pain relief
– Improved safety profiles 		– Higher cost
– Complex pharmacokinetics
– Still require appropriate prescribing

FAQ

  • How is morphine used in post-surgical pain management? Morphine is commonly used after surgery through several methods. It can be administered intravenously (through an IV), through patient-controlled analgesia (PCA) pumps where patients can self-administer small doses as needed, or through neuraxial methods (spinal or epidural). Clinical trials show morphine is effective for managing pain after procedures such as cesarean sections, laparoscopic surgeries, and orthopedic operations like hip replacements. It's often used alongside other pain management techniques as part of a multimodal approach to control post-surgical pain while minimizing side effects.
  • How does morphine compare to other pain medications in clinical trials? Clinical trials have compared morphine to various other pain medications, including other opioids like fentanyl and remifentanil, as well as non-opioid options. In one study, morphine was compared to intravenous ketamine for acute pain control in emergency departments. Other trials have evaluated morphine against combinations like ketorolac plus morphine for conditions such as renal colic. The research shows that while morphine remains effective, other medications may provide better pain relief in specific situations or may have fewer side effects. The choice between morphine and alternatives often depends on the specific clinical situation, patient characteristics, and the type of pain being treated.
  • What are the common side effects of morphine seen in clinical trials? Clinical trials consistently document several common side effects of morphine. These include respiratory depression (slowed breathing), nausea and vomiting, itching (pruritus), sedation or drowsiness, and constipation. Less common but serious side effects can include hypotension (low blood pressure), urinary retention, and confusion. Some trials specifically monitor for these effects, such as studies examining neuraxial morphine after cesarean sections. The frequency and severity of side effects often depend on the dose, route of administration, and individual patient factors. Researchers continue to investigate ways to maintain morphine's pain-relieving benefits while reducing these unwanted effects.
  • How is morphine being studied in special populations? Morphine is being studied carefully in several special populations where dosing and effects may differ. For pediatric patients, trials are examining appropriate dosing, pharmacokinetics (how the drug moves through the body), and safety profiles. In elderly patients, studies look at adjusted dosing due to potential changes in metabolism and increased sensitivity to side effects. Patients with obstructive sleep apnea are being studied to understand how morphine might affect their breathing patterns. Pregnant women undergoing cesarean sections are another important population where researchers are investigating optimal morphine dosing for post-operative pain while minimizing transfer to the newborn through breast milk.
  • What new formulations or delivery methods of morphine are being investigated? Clinical trials are exploring several innovative formulations and delivery methods for morphine. Extended-release formulations like morphine sulfate ER capsules aim to provide longer-lasting pain relief with fewer doses. Abuse-deterrent formulations are being developed to maintain pain control while reducing potential misuse. Novel delivery systems include nasal sprays for rapid pain relief and prolonged-release tablets that maintain steady blood levels. Some trials are examining combination products that pair morphine with other medications to enhance effectiveness or reduce side effects. These innovations aim to improve pain control, patient comfort, medication adherence, and safety profiles.

Ongoing Clinical Trials on MORPHINE

  • Study Comparing Serratus Plane Block, Capsaicin, and Botulinum Toxin Type A for Chronic Pain in Post-Mastectomy Patients

    Recruiting

    1 1 1
    Investigated drugs:
    France

  • Methoxyflurane Compared to Morphine for Pain Relief in Patients with Acute Myocardial Infarction Before Hospital Admission

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Methoxyflurane for Pain Relief in Patients with Heart Attack

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Reducing Postoperative Pain in Brain Surgery Patients Using Ropivacaine, Lidocaine, and Epinephrine

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Midazolam and Morphine for Symptom Relief in Elderly Patients at End of Life

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Belgium

Glossary

  • Analgesia: The relief of pain without loss of consciousness. Morphine provides analgesia by binding to opioid receptors in the brain and spinal cord.
  • Brief Pain Inventory (BPI): A widely used measurement tool that helps patients rate the severity of their pain and the impact of pain on daily functions. It's often used in clinical trials to assess the effectiveness of pain medications like morphine.
  • Caudal analgesia: A type of regional anesthesia where medication is injected through the sacral hiatus into the epidural space to block pain, commonly used in pediatric surgeries.
  • Duramorph: A brand name for preservative-free morphine sulfate injection, often used for neuraxial (spinal or epidural) administration to provide pain relief.
  • Emergence delirium: A state of confusion, disorientation, and possible agitation that occurs when a patient is waking up from anesthesia after surgery.
  • FLACC scale: Face, Legs, Activity, Cry, Consolability scale—a behavioral pain assessment tool used for children who cannot communicate their pain effectively.
  • Immediate-release (IR): A medication formulation designed to release the active ingredient quickly after administration, providing rapid pain relief but for a shorter duration.
  • Intrathecal: Referring to an injection into the spinal canal, specifically into the subarachnoid space where cerebrospinal fluid circulates around the brain and spinal cord.
  • Laparoscopic cholecystectomy: A minimally invasive surgical procedure to remove the gallbladder using a laparoscope (a thin, lighted tube) inserted through small incisions in the abdomen.
  • Laparoscopic sigmoidectomy: A minimally invasive surgical procedure to remove part of the sigmoid colon (the S-shaped section of the large intestine) using a laparoscope.
  • Multimodal analgesia: An approach to pain management that uses multiple medications and techniques acting through different mechanisms to maximize pain relief while minimizing side effects.
  • Naltrexone: An opioid antagonist medication that blocks the effects of opioids. Sometimes combined with morphine in abuse-deterrent formulations.
  • Neuraxial: Referring to administration of medication around the central nervous system, specifically via epidural or spinal (intrathecal) routes.
  • Numerical Rating Scale (NRS): A pain assessment tool where patients rate their pain on a scale from 0 (no pain) to 10 (worst possible pain).
  • Obstructive Sleep Apnea (OSA): A sleep disorder characterized by repeated episodes of complete or partial blockage of the upper airway during sleep, which can be worsened by opioid medications like morphine.
  • Patient-Controlled Analgesia (PCA): A method of pain control that allows patients to self-administer small doses of pain medication (often morphine) through a computerized pump when they need it.
  • Pericapsular Nerve Group (PENG) block: A regional anesthetic technique developed in 2018 for hip pain, involving injection of local anesthetic near the hip joint capsule to provide pain relief while sparing motor function.
  • Peridural catheter: A small tube placed in the epidural space (the space just outside the membrane covering the spinal cord) to deliver pain medication continuously.
  • Pharmacodynamics: The study of how drugs affect the body, including the relationship between drug concentration and effect.
  • Pharmacokinetics: The study of how the body processes a drug, including absorption, distribution, metabolism, and excretion.
  • Prolonged-release (PR): A medication formulation designed to release the active ingredient slowly over an extended period, providing longer-lasting pain relief.
  • QoR-40 questionnaire: Quality of Recovery-40, a 40-item quality of recovery scoring system that assesses five dimensions of recovery after surgery or anesthesia.
  • Remifentanil: A potent, short-acting synthetic opioid analgesic drug used during surgery for pain relief and sedation.
  • Richmond Agitation-Sedation Scale (RASS): A scale used to measure the agitation or sedation level of a patient, ranging from combative (+4) to unarousable (-5).
  • Transabdominal plane block (TAP): A regional anesthesia technique where local anesthetic is injected between the internal oblique and transversus abdominis muscles to reduce abdominal pain.
  • Visual Analog Scale (VAS): A measurement tool used to help patients rate the intensity of certain sensations and feelings, such as pain, on a continuous line between two endpoints.

References

  1. https://clinicaltrials.gov/study/NCT03403842
  2. https://clinicaltrials.gov/study/NCT04033094
  3. https://clinicaltrials.gov/study/NCT01825993
  4. https://clinicaltrials.gov/study/NCT00446069
  5. https://clinicaltrials.gov/study/NCT01538745
  6. https://clinicaltrials.gov/study/NCT00420992
  7. https://clinicaltrials.gov/study/NCT00477061
  8. https://clinicaltrials.gov/study/NCT02773316
  9. https://clinicaltrials.gov/study/NCT03926559
  10. https://clinicaltrials.gov/study/NCT05023473
  11. https://clinicaltrials.gov/study/NCT03045133
  12. https://clinicaltrials.gov/study/NCT01830296
  13. https://clinicaltrials.gov/study/NCT02456142
  14. https://clinicaltrials.gov/study/NCT00415597
  15. https://clinicaltrials.gov/study/NCT03010540
  16. https://clinicaltrials.gov/study/NCT02143141
  17. https://clinicaltrials.gov/study/NCT03127800
  18. https://clinicaltrials.gov/study/NCT06621849
  19. https://clinicaltrials.gov/study/NCT00737737
  20. https://clinicaltrials.gov/study/NCT01298778
  21. https://clinicaltrials.gov/study/NCT00768183
  22. https://clinicaltrials.gov/study/NCT03035578
  23. https://clinicaltrials.gov/study/NCT07076641
  24. https://clinicaltrials.gov/study/NCT00751478
  25. https://clinicaltrials.gov/study/NCT01071499